US healthcare funds target changing sector

SV Life Sciences and Linden have closed funds totaling some $900m to target a sector bracing for big regulatory changes.

5 January 2013•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.